Presentation is loading. Please wait.

Presentation is loading. Please wait.

Molecular Genetics of Sodium Channel Myotonias Michael Hanna

Similar presentations


Presentation on theme: "Molecular Genetics of Sodium Channel Myotonias Michael Hanna"— Presentation transcript:

1 Molecular Genetics of Sodium Channel Myotonias Michael Hanna
CINCH NDM Meeting Kansas 3 June 2007 MRC Centre for Neuromuscular Disease Institute of Neurology Queen Square London

2 Overview Sodium channel gene Known phenotype-genotype links
Review recent UK study of SCN4A gene and myotonia

3 Complete Ion channel without accessory subunits
I II III IV Nav1.4 Cav1.1 + I IV x1 III II COOH NH x4 Kir2.1 NH COOH C D B E F G H I J K L M N O P Q R A NH COOH + - CLC-1 x2

4 Skeletal muscle Sodium channel gene Chromosome 17q 24 exons 36 point mutations all missense Multiple founders Impaired inactivation +

5 Phenotype Common genotype
Hypo PP R672H/G/S Hyper PP T704M K sensitive normoPP R675G/Q/W HyperPP/PC R1448C/H Cold induced HypoPP/myt P1158S Paramyotonia congenita T1313A/M Painful cong myotonia V445M PAM-MF MP G1306A/V/E

6 Queen Square PP Database
Genetically defined June 2007: CACNA1S 26 R528H 34 R1239H 1 R1239G SCN4A T704M 13 M1592V 4 R675G 1 R672S

7 SCN4A genotype-phenotype
40 T704M HyperPP+/- myt 13 M1592V HyperPP+/- myt 4 R675G K sens-Normo R672S HypoK

8 UK study Sodium channel Myotonia
Aim –identify a sodium channel myotonia cohort Source-UK NSCAG Clinical database muscle channelopathies Inclusion criteria- “relaxed” Paramyotonia Prominent history cold exacerbation +/-weakness EMG myotonia DM1 /DM2 excluded SCN4A automated DNA analysis and detailed clinical analysis of mutation positive vs negative cases

9 UK study Sodium channel Myotonia
39 cases identified 27 exon 22/exon SCN4A neg 3/27 PAM mts 2/27 new mts 2/12 T704M 1/12 new mts

10 Mutation Reported Phenotypes Phenotypes in UK Cohort Frequency in UK cohort (patients/kindred) Q270K**** PMC 1/1 T704M HyperPP HyperPP/PMC 2/1 G1306A PAM (MF) PMC/PAM G1306E PAM (MP) T1313M 10/6 R1448C 4/2 R1448H 2/2 R1448L**** - G1456E 3/1 F1473S 1/ [3/1] V1589M PAM L1436P****

11 PAM mutations PMC clinical phenotype
G1306E Myotonia Permanens G1306A Myotonia Fluctuans Clinical impression vs EMG criteria

12 Mutation Frequency in our cohort (patients/kindred) ***Q270K 1/1*** D1-S5 T704M 2/1 G1306A G1306E 1/1 T1313M 10/6 R1448C 4/2 R1448H 2/2 ***R1448L 1/1*** D4-S4 G1456E 3/1 F1473S V1589M ***L1436P 1/1 **** D4-S4 {I693T 1/1}

13 R1448L Typical PMC Paramyotonia Cold exacerbation myotonia
Cold induced weakness Additional features – sensorineural deafness, generalised chorea ?unrelated

14

15 L1436P I693T

16 L1436P PMC phenotype Newcastle Myositis-immunosuppression
Coincidence?/ other cases

17 L1436P I693T

18 L1436P I693T

19 Q270K PMC Marked pain Domain I mutations and pain? Treatment resistant

20

21 L1436P I693T

22 Mutation “negative” cases
Clear paramyotonia with cold exacerbation Older age at onset Prominent painful myotonia Upper and lower limbs equally affected Fixed weakness ? Additional SCN4A mutations, ?CLCN1 ? Non-genetic phenocopies

23 Summary Exon 22/24 hotspot for PMC mutations DNA screening strategy
Extending SCN4A analysis 75% hit rate Clinical distinction between PAM-PMC not always easy ? Genetic overlap cf EMG ? Further heterogeneity associated with PMC phenotype

24 Ion Channel Group Queen Square
Research NSCAG Service Doreen Fialho Veronica Tann Susie Tomlinson Martin Koltzenburg Dimitri Kullmann Emma Stanley Nick Wood Cath Woodward Mary Davis Sanj Rajakulendran Mary Sweeney Emma Matthews Dennis Stevens Stephanie Schorge Andrew Haworth Tracey Graves Hugh Bostock Funding Support MRC, Wellcome Trust, ERF, BRT, ULCH-NHS Trust Special Trustees DoH NSCAG. Action Research, CINCH

25

26

27 Inherited mutations alter ion channel function and structure and cause human disease
Copyright ©2005 American Society for Clinical Investigation

28 Clinical Classification Periodic Paralysis Nondystrophic Myotonias Andersen Tawil Syndrome Hypo- kalaemic PP Hyper- kalaemic PP Paramyotonia congenita Myotonia congenita VG Ca2+ channel (Dihydropyridine receptor) Cav1.1 (CACNA1S) VG skeletal muscle Na+ channel Nav1.4 (SCN4A) Molecular Classification VG skeletal muscle Cl- channel CLC-1 (CLCN1) Inward rectifying K+ channel Kir 2.1 (KCNJ2)

29 Skeletal muscle Na+ channel NaV1.4

30


Download ppt "Molecular Genetics of Sodium Channel Myotonias Michael Hanna"

Similar presentations


Ads by Google